21 May 2013
Keywords: generic, competition, hits, kaken, altz, pharmaceuticals, says
Article | 24 June 1996
Kaken Pharmaceuticals says turnover was down 10.7% for the year ended
March 1996 at 70.34 billion yen ($644.7 million) as a result of generic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 February 1996
© 2013 thepharmaletter.com